Search

Displaying results 7801 - 7810 of 10000 in total
  1. Drug

    Ladostigil

    go.drugbank.com/drugs/DB16213
    Investigational

    Ladostigil is under investigation in clinical trial NCT01429623 (A 3 Year Study to Evaluate the Safety and Efficacy of Low Dose Ladostigil in Patients With Mild Cognitive Impairment).

  2. Drug

    Astegolimab

    go.drugbank.com/drugs/DB16386
    Investigational

    Astegolimab is under investigation in clinical trial NCT04386616 (A Study to Evaluate the Safety and Efficacy of MSTT1041A (Astegolimab) or UTTR1147A in Patients With Severe COVID-19 Pneumonia).

  3. Drug

    Bentracimab

    go.drugbank.com/drugs/DB16659
    Investigational

    Bentracimab is under investigation in clinical trial NCT04286438 (Bentracimab (PB2452) in Ticagrelor-treated Patients With Uncontrolled Major or Life-threatening Bleeding or Requiring Urgent Surgery or

  4. Drug

    ATX-914

    go.drugbank.com/drugs/DB12673
    Investigational

    Axt914 is under investigation in clinical trial NCT00417261 (Safety, Tolerability, Pharmacodynamic and Pharmacokinetic Effects of Single and Multiple-Doses of ATF936 and AXT914 Administered Orally in Healthy

  5. Drug

    LYB014

    go.drugbank.com/drugs/DB33993
    Experimental

    LYB014 is under investigation in clinical trial NCT07831226 (Safety and Immunogenicity of the Recombinant Malaria Vaccines in Healthy Adults Aged 18-59 Years).

  6. Drug

    ALN-6457

    go.drugbank.com/drugs/DB33986
    Experimental

    ALN-6457 is under investigation in clinical trial NCT07832370 (A Trial of ALN-6457 in Adult Participants With Symptomatic Prion Disease (PrD)).

  7. Drug

    LYB017

    go.drugbank.com/drugs/DB33994
    Experimental

    LYB017 is under investigation in clinical trial NCT07831226 (Safety and Immunogenicity of the Recombinant Malaria Vaccines in Healthy Adults Aged 18-59 Years).

  8. Drug

    LYB027

    go.drugbank.com/drugs/DB33995
    Experimental

    LYB027 is under investigation in clinical trial NCT07831226 (Safety and Immunogenicity of the Recombinant Malaria Vaccines in Healthy Adults Aged 18-59 Years).

  9. Drug

    SL1CC

    go.drugbank.com/drugs/DB34006
    Experimental

    SL1CC is under investigation in clinical trial NCT07841002 (CLL-1-Targeted In Vivo CAR-T Cell Immunotherapy for Relapsed/Refractory Acute Myeloid Leukemia).

  10. Drug

    Bacillus calmette-guerin substrain danish 1331 live antigen

    go.drugbank.com/drugs/DB12386
    Investigational

    BCG SSI has been used in trials studying Tuberculosis.